Showing results (21-30 of 60) with videos related to
Sort By:
Pageof 6
Blood|July 5, 2003
Overexpression of the Notch ligand, Jagged-1, induces alloantigen-specific human regulatory T cellsEric S Yvon, Stephane Vigouroux, Raphael F Rousseau, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 10, 2011
In vitro comparison of three different chimeric receptor-modified effector T-cell populations for leukemia cell therapyIrene Pizzitola, Valentina Agostoni, Elisabetta Cribioli, et al.Blood|March 6, 2004
CD40 activation of BCP-ALL cells generates IL-10-producing, IL-12-defective APCs that induce allogeneic T-cell anergyGiovanna D'Amico, Marisa Vulcano, Cristina Bugarin, et al.Blood|November 13, 2004
Molecular transfer of CD40 and OX40 ligands to leukemic human B cells induces expansion of autologous tumor-reactive cytotoxic T lymphocytesEttore Biagi, Gianpietro Dotti, Eric Yvon, et al.Journal of Pediatric Hematology/Oncology|January 10, 2009
PTX3 as a potential novel tool for the diagnosis and monitoring of pulmonary fungal infections in immuno-compromised pediatric patientsEttore Biagi, Marina Col, Maddalena Migliavacca, et al.Journal of Virology|September 27, 2003
Induction of antigen-specific regulatory T cells following overexpression of a Notch ligand by human B lymphocytesStéphane Vigouroux, Eric Yvon, Hans-Joachim Wagner, et al.Blood|February 17, 2005
Human cytotoxic T lymphocytes with reduced sensitivity to Fas-induced apoptosisGianpietro Dotti, Barbara Savoldo, Martin Pule, et al.Biomed Research International|October 24, 2015
Full GMP-compliant validation of bone marrow-derived human CD133(+) cells as advanced therapy medicinal product for refractory ischemic cardiomyopathyDaniela Belotti, Giuseppe Gaipa, Beatrice Bassetti, et al.Cytotherapy|March 15, 2016
Development of advanced therapies in Italy: Management models and sustainability in six Italian cell factoriesGiuseppe Gaipa, Martino Introna, Josee Golay, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 19, 2013
Upregulation of adhesion molecules on leukemia targets improves the efficacy of cytotoxic T cells transduced with chimeric anti-CD19 receptorDavid Laurin, Virna Marin, Ettore Biagi, et al.Pageof 6